10 October 2023
10 October 2023
In an era of technological advancements, we are now more connected than ever – but what are the implications and how can technology tackle the issue of metal health?
As the prevalence of neurodegenerative diseases rapidly rises, researchers at the ongoing HLTH 2023 conference highlighted how biomarker development is urgently needed for treatment breakthroughs to occur.
Artificial intelligence (AI) is an incredibly fast-growing industry and this year it is the main topic on everyone’s lips at HLTH 2023.
The new dashboard uses generative AI to navigate medical device regulation and save up to 236 hours on regulatory submissions.
Johnson & Johnson Medtech’s orthopaedics division DePuy Synthes has secured FDA 510(k) clearance for its TriATLIS Spine System and Navigation Enabled Instruments.
Uncover how 3D bioprinting is changing the future of personalised medicine and medical devices in an interview with Vidmantas Šakalys CEO of Vital 3D Technologies.
The randomised controlled clinical trial will enrol up to 1,500 patients in Europe and the US.
The test offers clear data that will enable healthcare providers to determine the next better step in the screening process.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Although metaverse technologies could reinvent healthcare approaches and bring new experiences to healthcare providers and patients, adoption is still at an early stage. There are currently few use cases in the healthcare industry. The metaverse needs to overcome major challenges for healthcare, including regulation and data privacy concerns. Evidence of proven use cases and participation by a critical mass of users are imperative to drive a shift in metaverse investment.
Give your business an edge with our leading industry insights.
